Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

Genetics in Medicine(2023)10.1016/j.gim.2023.100925Source: DataRank Database

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension is a research paper published in Genetics in Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 75 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access75 citations

Download PDF

Cite:

Linked data & code

omim

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 12.40)OA: bronzeTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (76)

Micheala A. Aldred ORCID,Srimmitha Balachandar ORCID,Dennis Dooijes ORCID,Christina A. Eichstaedt ORCID,Stefan Gräf ORCID

Live enrichment

PubMed:37422716 PMC:PMC10766870 OpenAlex:https://openalex.org/W4383215735

Instituto de Salud Carlos III

Grant: PI21/01593

National Institutes of Health

Grant: U24HG009650

National Heart, Lung, and Blood Institute

Grant: R35HL140019

Diabetes UK

Grant: SBF005\1115

American Heart Association

Grant: 834024

NHLBI NIH HHS

Grant: R24 HL105333

NHLBI NIH HHS

Grant: U01 HL125218

NHLBI NIH HHS

Grant: K23 HL151892

British Heart Foundation

Grant: FS/SBSRF/22/31025

Department for Business, Energy and Industrial Strategy, UK Government

Federación Española de Enfermedades Raras

Academy of Medical Sciences

Alberta Mennega Stichting

British Heart Foundation

Wellcome Trust

FWCI

12.40

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.gimjournal.org/article/S1098360023009383/pdf

publisherhttp://www.gimjournal.org/article/S1098360023009383/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1098360023009383?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1098360023009383?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.gim.2023.100925

Fields of Study

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisAdultChildHumansPulmonary Arterial HypertensionMutationHypertension, PulmonaryGenetic Predisposition to DiseaseGenetic TestingBone Morphogenetic Protein Receptors, Type IIAdenosine TriphosphatasesMembrane Transport ProteinsActivin Receptors, Type IIProtein Serine-Threonine KinasesBone Morphogenetic Proteins

MeSH Terms

Pulmonary Arterial HypertensionAdenosine TriphosphatasesAdultChildGenetic TestingHumansHypertension, PulmonaryMutationProtein Serine-Threonine KinasesBone Morphogenetic ProteinsGenetic Predisposition to DiseaseMembrane Transport ProteinsActivin Receptors, Type IIBone Morphogenetic Protein Receptors, Type II

Keywords

GenePulmonary hypertensionMedicineInternal medicineCardiologyGeneticsBioinformaticsBiologyMolecular diagnosisPulmonary Arterial HypertensionGenomic Medicine

Sustainable Development Goals

SDG 0: Good health and well-being